These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2350907

  • 21. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C, Blumberg A.
    Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
    [Abstract] [Full Text] [Related]

  • 22. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
    Faller B, Slingeneyer A, Waller M, Michel C, Grützmacher P, Müller HP, Barany P, Grabensee B, Issad B, Schmitt H.
    Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA, Verberckmoes R, Michielsen P, Koene RA.
    Nephrol Dial Transplant; 1989 Sep; 4(9):782-6. PubMed ID: 2516609
    [Abstract] [Full Text] [Related]

  • 26. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
    Acharya VN, Sinha DK, Almeida AF, Pathare AV.
    J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
    [Abstract] [Full Text] [Related]

  • 27. The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A.
    Adv Perit Dial; 1997 Aug; 13():109-12. PubMed ID: 9360661
    [Abstract] [Full Text] [Related]

  • 28. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M, Boguszewska-Baczkowska A, Jelonek A.
    Pol Tyg Lek; 1997 Aug; 49(6-7):135-6. PubMed ID: 8090665
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y.
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [Abstract] [Full Text] [Related]

  • 31. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B, Grujić-Adanja G.
    Srp Arh Celok Lek; 1997 Jan; 125(5-6):163-7. PubMed ID: 9265238
    [Abstract] [Full Text] [Related]

  • 32. Erythropoietin 1991--an overview.
    Eschbach JW.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):3-9. PubMed ID: 1928076
    [Abstract] [Full Text] [Related]

  • 33. Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD.
    Eidemak I, Friedberg MO, Ladefoged SD, Løkkegaard H, Pedersen E, Skielboe M.
    Nephrol Dial Transplant; 1992 Oct; 7(6):526-9. PubMed ID: 1320232
    [Abstract] [Full Text] [Related]

  • 34. Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease.
    Salvarani C, Lasagni D, Casali B, Macchioni P, Boiardi L, Rossi F, Rivasi P, Portioli I.
    J Rheumatol; 1991 Aug; 18(8):1168-71. PubMed ID: 1941817
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y, Jirajan B, Krairithichai U, Jantavanich N.
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [Abstract] [Full Text] [Related]

  • 37. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G, Bailie GR, Clement C, Wong E.
    Perit Dial Int; 1992 Sep; 12(1):34-6. PubMed ID: 1543777
    [Abstract] [Full Text] [Related]

  • 38. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
    Macdougall IC, Cavill I, Davies ME, Hutton RD, Coles GA, Williams JD.
    Contrib Nephrol; 1989 Sep; 76():219-26. PubMed ID: 2582780
    [No Abstract] [Full Text] [Related]

  • 39. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK, Leung CB, Lui SF, Leung JC, Shek AC, Lai KN.
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [Abstract] [Full Text] [Related]

  • 40. Low-dose subcutaneous erythropoietin in continuous ambulatory peritoneal dialysis.
    Rotellar C, Mazzoni MJ, Mosher WF, Aminrazavi M, Bauer A, Rakowski TA, Schreiner GE, Winchester JF.
    Am J Hematol; 1991 May; 37(1):31-3. PubMed ID: 2024637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.